Dr. Michael Zaki, MD

Dr. Zaki practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. Zaki's NPI, 1992199814, was assigned on March 28, 2015. Dr. Zaki graduated from David Geffen School of Medicine at UCLA in 2015. Dr. Zaki holds Florida license ME142368.

Dr. Zaki's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Dr. Zaki's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. The medical group on file is South Florida ENT Associates. Dmand AI also links Dr. Zaki to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaki practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Zaki's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Zaki is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Zaki's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Zaki treats.

CMS data shows 702 Medicare services from Dr. Zaki across 10 procedure codes in 2024, for 237 Medicare patients. Medicare paid $61,618 for them. Every service was in an office.

CMS counts 237 Medicare patients who saw Dr. Zaki in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zaki's median patient age at 52, with 50% women.

In 2024, Dr. Zaki wrote 1,151 Medicare Part D claims for 388 patients. 97% of them were for generic drugs. CMS names the drug for 1,070 of them, across 16 drugs with 11 or more claims each, at $24,577 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Zaki for performance year 2024, reported individually. Dr. Zaki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Zaki, published from 2014 to 2018. The most frequent topics are Epistaxis. Dr. Zaki's most frequent co-authors are Soly Baredes, MD, Sei Y. Chung, MD and Doniel G. Drazin.

CMS Open Payments shows 47 general payments to Dr. Zaki from 9 drug and device companies from 2024 to 2025. Travel and lodging make up the largest share, 55% of the total. Stryker Corporation paid the most, $1,780.

Dr. Zaki graduated from David Geffen School of Medicine at UCLA in 2015.

Dr. Zaki is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.